Committee reports medical‑marijuana provision moving pharmacy oversight to LDH with higher per‑location fee

3718074 · June 8, 2025

Get AI-powered insights, summaries, and transcripts

Subscribe
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

House Bill 657, shifting medical‑marijuana pharmacy oversight to the Department of Health, was reported favorable after testimony that LDH calculated a per‑location fee of $22,500 to cover agency costs; pharmacies agreed to the fee in the committee.

The committee on June 8 reported House Bill 657 favorable. Representative Reiser presented the bill, which moves administration of certain medical‑marijuana pharmacy licensing responsibilities from the Pharmacy Board to the Louisiana Department of Health.

Representatives and industry witnesses said LDH ran a fee analysis and estimated a per‑location fee of $22,500; the sponsor and industry representatives said pharmacies and LDH had agreed that the fee would cover the program’s costs. Danny Ford of the Louisiana Association for Therapeutic Alternatives confirmed the parties had worked with LDH on the fee amount and supported reporting the bill favorable.

The bill’s supporters listed in committee included Danny Ford, Peter Prevost (Louisiana Therapeutics Association) and several industry representatives. Senator Andrews moved to report the bill favorable; there were no objections.